Quote
466.00
-7.19 (-1.52%)
We have scored 45 news catalysts on HCA (HCA) over the past 12 months. Coverage across the window leans mixed (average ticker sentiment +0.04). Most of the impact sits in sector healthcare and institutional appeal.
Market cap
—
P/E
—
EPS
—
Beta
—
52W range
—
Day range
460.93–477.88
Open
477.88
Prev close
473.19
Volume
765.5K
Avg volume
—
Dividend
—
IPO
—
No scored news tagged HCA or its network in the window yet.
Show more HCA articles →Analysts publish price targets on HCA, and they disagree. Where the share price actually sits among them shows which of their arguments the market is buying — and which it is ignoring.
19 analyst price targets from $369 to $579
as of 2026-09-23
The market is within 1% of the median target — broadly agreeing with the analysts.
The reconstruction
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about HCA — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for HCA: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
The price sits within 1% of the median published model, meaning it broadly agrees with the middle of the analyst spread and has already absorbed the recent guidance cuts that pushed targets downward.
What the disagreement turns on
Whether the shift toward lower-paying government insurance (Medicaid) is a temporary disruption that stabilizes, or a permanent structural change that erodes margins further — and the wired data can only track the resulting volume changes, not the pricing itself.
The price pays for
It declines to pay for
Written by a language model from the published models, the reported segments and a reverse-DCF — not a recommendation, and not a house view.
Claim by claim
Computed at $438 on 2026-09-23 — the quote has since moved +6%, so read this as a record of what was priced in then, not now.
